FDA 101: Dietary Supplements

The law defines dietary supplements in part as products taken by mouth that contain a “dietary ingredient.” Dietary ingredients include vitamins, minerals, amino acids, and herbs or botanicals, as well as other substances that can be used to supplement the diet. Dietary supplements come in many forms, including tablets, capsules, powders, energy bars, and liquids….

FDA D.I.S.C.O. Burst Edition: FDA approval of Welireg (belzutifan) for adult patients with von Hippel-Lindau disease who require therapy for associated renal cell carcinoma, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring immediate surgery

Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we have a quick update on another recent FDA cancer drug approval. On August 13, 2021, FDA approved belzutifan (brand name Welireg),…

Stop Using Certain N95 Respirators Manufactured by Shanghai Dasheng – Letter to Health Care Providers

August 25, 2021  The U.S. Food and Drug Administration (FDA) is alerting health care facility risk managers, procurement staff, and health care personnel to stop using certain N95 respirators manufactured by Shanghai Dasheng Health Products Manufacturing Co., Ltd. (Shanghai Dasheng). The Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health…

FDA D.I.S.C.O. Burst Edition: FDA approval of Lenvima (lenvatinib) in combination with Keytruda (pembrolizumab) for first-line treatment of adult patients with advanced renal cell carcinoma

Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we’ll provide a quick update on a recent FDA cancer drug approval. On August 10, 2021, FDA approved the combination of lenvatinib…

Baxter Issues Urgent Medical Device Correction for All Spectrum IQ Infusion Pumps to Reinforce Important Safety Information Regarding Best Practices for Customer-Initiated IT Network Updates

Summary Company Announcement Date: August 24, 2021 FDA Publish Date: August 24, 2021 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Multiple Connectivity Errors Company Name: Baxter International Inc. Brand Name: Brand Name(s) Spectrum IQ Product Description: Product Description Infusion Pumps Company Announcement Baxter International Inc. announced today it has issued an Urgent…

Cardinal Health Issues Nationwide Recall of Select Monoject™ Flush Prefilled Saline Syringes

Summary Company Announcement Date: August 19, 2021 FDA Publish Date: August 20, 2021 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Products have been found to reintroduce air into the syringe after the air has been expelled Company Name: Cardinal Health Brand Name: Brand Name(s) Product Description: Product Description Flush Prefilled Saline Syringes…